Company Overview
Snapshot
Founded in March 2010 by Ehud Marom, Stem Cell Medicine operates with 11–50 employees. The company has raised $5.5 million across two funding rounds, with Crossroad Venture Capital Fund participating in one round. In March 2019, the company secured a grant from The Israeli Ministry of Economy.
Business overview
Stem Cell Medicine is a biotechnology company focused on developing second-generation cell therapy products. These products are designed for use as standalone treatments or in combination with pharmaceuticals, primarily targeting neurological indications such as multiple sclerosis, pain, and neuromuscular injuries. The company also manages the production, registration, and marketing of its therapeutic solutions, operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
Strategic signal
In January 2019, Stem Cell Medicine licensed exosome technology for treating autism from Ramot at Tel Aviv University. This strategic licensing agreement signals the company's commitment to expanding its therapeutic pipeline into new neurological areas and leveraging external research for product development, indicating a proactive approach to addressing unmet medical needs in neurodevelopmental disorders.
Log in to access full profile ›Company Intelligence Q&A
- When was Stem Cell Medicine founded?
- Stem Cell Medicine was founded in March 2010.
- Who are the founders of Stem Cell Medicine?
- Ehud Marom is the founder of Stem Cell Medicine.
- What significant grant did Stem Cell Medicine receive?
- In March 2019, Stem Cell Medicine secured a grant from The Israeli Ministry of Economy, amounting to $5.5 million.
- What technology did Stem Cell Medicine license in 2019?
- In January 2019, Stem Cell Medicine licensed exosome technology for treating autism from Ramot at Tel Aviv University.
- What is Stem Cell Medicine's primary focus in product development?
- Stem Cell Medicine focuses on developing second-generation cell therapy products for neurological indications such as multiple sclerosis, pain, and neuromuscular injuries.